EQUITY (Detail 2) - $ / shares |
6 Months Ended | 12 Months Ended |
|---|---|---|
Feb. 29, 2020 |
Aug. 31, 2019 |
|
| Number of Options Outstanding | ||
| Number of Options Outstanding | 234,000 | |
| Number of shares granted during period | 74,000 | |
| Number of Options Exercised | 0 | |
| Number of Options Forfeited/canceled | (26,166) | |
| Number of Options Outstanding | 281,834 | 234,000 |
| Weighted Average Exercise Price Options Outstanding | ||
| Weighted Average Exercise Price, Outstanding | $ 3.88 | |
| Weighted Average Exercise Price, Granted | 2.48 | |
| Weighted Average Exercise Price, Forfeited/canceled | 3.31 | |
| Weighted Average Exercise Price, Outstanding | $ 3.57 | $ 3.88 |
| Weighted Average Remaining Contractual life, Outstanding (in years) | 9 years 4 months 28 days | 9 years 9 months 10 days |
| Weighted Average Remaining Contractual life, Granted (in years) | 10 years | |
| Weighted Average Remaining Contractual life, Forfeited (in years) | 9 years 6 months 29 days |
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards forfeited. No definition available.
|
| X | ||||||||||
- Definition Represents period of stock option granted during period. No definition available.
|
| X | ||||||||||
- Definition For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price of options that were either forfeited or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|